Tyson Foods, Inc. (TSN) Earnings
Tyson Foods, Inc. is expected to report next earnings on August 3, 2026 (in NaN days), with a consensus EPS estimate of $1.05. TSN has beaten EPS estimates in 7 of its last 12 reported quarters (average surprise +16.7% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 4, 2026 | $0.76 | $0.87 | +14.5% | $13.7B | +0.2% |
| Feb 2, 2026 | $1.01 | $0.97 | -4.0% | $14.3B | +5.7% |
| Feb 3, 2025 | $0.79 | $1.14 | +44.3% | $13.6B | +3.6% |
| Nov 13, 2023 | $0.33 | $0.37 | +12.1% | $13.3B | -2.8% |
| Nov 14, 2022 | $1.73 | $1.63 | -5.8% | $13.7B | +1.8% |
| Feb 7, 2022 | $1.90 | $2.87 | +51.1% | $12.9B | +6.3% |
| Nov 15, 2021 | $2.20 | $2.30 | +4.5% | $12.8B | +3.1% |
| Feb 11, 2021 | $1.58 | $1.94 | +22.8% | $10.5B | -3.4% |
| Nov 16, 2020 | $1.19 | $1.95 | +63.9% | $11.5B | +11.8% |
| May 4, 2020 | $1.04 | $0.77 | -26.0% | $10.9B | -26.0% |
| Feb 6, 2020 | $1.66 | $1.66 | +0.0% | $10.8B | +0.0% |
| Nov 12, 2019 | $1.29 | $1.21 | -6.2% | $10.9B | -6.2% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q2 FY2026 · May 4, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
• Overall pleased with second quarter performance and raising AOI guidance for the year. • Focused on disciplined execution, diversified multi-protein portfolio, and balanced capital allocation. • Shift to segment operating income working as intended, empowering business leaders. • Chicken delivered strong quarter with 12.2% margin, volume growth, and improved execution. • Prepared Foods saw segment operating income increase despite higher commodity costs, with share gains and innovation. • Beef completed manufacturing footprint optimization, expects benefits in coming quarters. • Pork performed well in stable environment. • International segment continued momentum. • Using AI-driven insights for innovation, like Jimmy Dean protein breakfast platform. • Retail performance superior to competitors, digital growth stronger than in-store
Guidance
• Full year sales expected to be up 2% to 4% year over year. • Total company adjusted operating income range $2.2 to $2.4 billion, increased by $100 million at midpoint. • Interest expense approximately $365 million, lower than previous guidance by $5 million; tax rate around 25%. • CapEx expected between $700 million and $1 billion; free cash flow range $1.2 to $1.8 billion. • Prepared Foods segment operating income expected $1.25 to $1.35 billion. • Chicken segment operating income range $1.9 to $2.05 billion, increased by $200 million at midpoint. • Beef segment operating income loss between $500 and $350 million. • Pork segment operating income $250 to $300 million. • International segment operating income $150 to $200 million. • Corporate expenses and amortization anticipated $950 to $975 million
Segment performance
Chicken: Segment operating income $523 million, 12.2% margin; sales up 3.5% year over year, total chicken volume up 1.7%, retail and food service volumes grew nearly three times faster than total volume. Prepared Foods: Segment operating income $352 million, margin 14%; sales grew 4.8%, volume grew 0.4%, gained share in volume, dollars, and units. Beef: Segment results reflected cattle cycle volatility; completed manufacturing footprint optimization, expects benefits to build, outlook for remainder of year implies lower losses in back half than front half. Pork: Performed well in stable operating environment, segment operating income $41 million, margin 2.6%; reliable pork raw materials and integrated network improving mix. International: Continued momentum, benefits from increasing demand for protein and diversified portfolio
Analyst Q&A
Q: Congrats on strong results and asked about sustainability of chicken performance and role of genetics.
A: Momentum real, not commodity-driven, genetics business contributing about a third of quarter-over-quarter improvement, new genetics line with more upside to come.
Q: Pivot to prepared foods, asked about why gaining market share.
A: Strong demand, disciplined execution, multi-year strategy working, control of controllables like pricing, promotion, distribution, service.
Q: On pork, asked about confidence in guidance range.
A: Balanced market supporting, consumer demand good relative to beef, some seasonal and operational factors in quarter not expected to repeat.
Q: Update on beef plant closure and pork supply.
A: Beef business moving forward, pork supply outlook stable, no interruptions from disease yet, light farrowing watched but not red flag.
Q: Clarification on encouragement of momentum and what it means.
A: Room for earnings upside from continuous improvement, operational excellence end to end.
Q: Questions on chicken cost position and genetics impact.
A: Chicken business different from commodity peers, genetics business has potential for significant segment operating income, back half expected to be as good as or better than first half